Diane H. Gulyas
CIK 1466674 · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.51M
Companies
6
Total Filings
55
Lifetime Open-Market Net
$314.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXPD | Director | 24,541 | $181.41 | $4.45M | $0 | 10 | 2026-05-07 |
| NGVT | Director | 18,535 | $77.11 | $1.43M | $50.4K | 10 | 2026-05-01 |
| DAR | Director | 10,860 | $57.80 | $627.7K | $0 | 3 | 2019-05-09 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 17,344 | $0.34 | $5.9K | $178.2K | 13 | 2018-03-05 |
| EXPEDITORS INTERNATIONAL OF WASHINGTON INC (LVLT) Delisted | Director | 11,711 | — | — | $0 | 2 | 2017-05-22 |
| NAVISTAR INTERNATIONAL CORP (NAV) Delisted | Director | 2,706 | $44.50 | $120.4K | $86.1K | 8 | 2012-04-03 |
Recent Filings · Page 5 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-10 | — | Buy (P) | +2,000 | $196.6K | |
| 2015-03-09 | — | Buy (P) | +2,000 | $196.6K | |
| 2015-02-10 | — | Buy (P) | +1,000 | $100.2K | |
| 2014-08-12 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +400 | $27.7K | EDGAR |
| 2014-03-24 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +1,603 | -$67.9K | EDGAR |
| 2013-08-19 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +1,150 | $49.5K | EDGAR |
| 2013-07-22 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +3,034 | $0 | EDGAR |
| 2012-04-03 | NAVISTAR INTERNATIONAL CORP (NAV) Delisted | Grant (A) | +490 | $0 | EDGAR |
| 2011-12-15 | NAVISTAR INTERNATIONAL CORP (NAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-09-13 | NAVISTAR INTERNATIONAL CORP (NAV) Delisted | Buy (P) | +1,300 | $48.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.